Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1192, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/infliximab: Miliary tuberculosis: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1422, 2012-01 ,pp. :
Access to resources
Recommend
Adalimumab/infliximab: Histoplasmosis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :
Adalimumab/infliximab: Worsening of (or de novo) psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. :
Adalimumab/infliximab: Various toxicities: 30 case reports
Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. :
Adalimumab/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :